Epigenetics Market Report 2026
Global Outlook – By Product (Reagents, Enzymes, Instruments, Kits), By Technology (DNA Methylation, Histone Methylation, Histone Acetylation, Large Noncoding RNA, MicroRNA Modification, Chromatin Structures), By Application (Oncology, Metabolic Diseases, Developmental Biology, Immunology, Cardiovascular Diseases, Other Applications), By End-User (Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Other End Users) – Market Size, Trends, Strategies, and Forecast to 2030
Epigenetics Market Overview
• Epigenetics market size has reached to $12.74 billion in 2025 • Expected to grow to $35.01 billion in 2030 at a compound annual growth rate (CAGR) of 22.3% • Growth Driver: Precision Medicine Drives Growth Of Epigenetics Market • Market Trend: AI-Driven Analytics Transforming Epigenetics Research And Data Analysis • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Epigenetics Market?
Epigenetics is a change in gene activity transmitted to younger cells without modifying the DNA sequence. Epigenetic processes are natural and necessary for many organisms to work, but unusual occurrences can cause disorders, such as various types of cancer, reproductive illnesses, and cardiovascular illnesses. Epigenetics is used detect a type of cancers earlier. The main products used in epigenetics market are reagents, enzymes, instruments and kits. Reagents are compounds or substances that are used for chemical analysis or epigenetic testing. DNA methylation, histone methylation, histone acetylation, large noncoding RNA, microRNA modification and chromatin structures are the technologies used in epigenetics. The application included oncology, metabolic diseases, developmental biology, immunology, cardiovascular diseases and other applications. These epigenetics are used by academic and research institutes, pharmaceutical, and biotechnology companies, contract research organizations and other end users.
What Is The Epigenetics Market Size and Share 2026?
The epigenetics market size has grown exponentially in recent years. It will grow from $12.74 billion in 2025 to $15.62 billion in 2026 at a compound annual growth rate (CAGR) of 22.6%. The growth in the historic period can be attributed to increasing cancer research activities, expansion of academic genomics research, availability of advanced sequencing instruments, growing focus on molecular diagnostics, rising funding for life sciences research.What Is The Epigenetics Market Growth Forecast?
The epigenetics market size is expected to see exponential growth in the next few years. It will grow to $35.01 billion in 2030 at a compound annual growth rate (CAGR) of 22.3%. The growth in the forecast period can be attributed to increasing investments in precision medicine, rising adoption of epigenetic therapeutics, expansion of personalized oncology treatments, growing use of ai-driven genomic analysis, increasing collaboration between pharma and research institutes. Major trends in the forecast period include increasing use of epigenetic biomarkers in oncology, rising adoption of high-throughput epigenetic analysis tools, growing demand for dna methylation assays, expansion of epigenetics-based drug discovery, enhanced integration of bioinformatics platforms.
Global Epigenetics Market Segmentation
1) By Product: Reagents, Enzymes, Instruments, Kits 2) By Technology: DNA Methylation, Histone Methylation, Histone Acetylation, Large Noncoding RNA, MicroRNA Modification, Chromatin Structures 3) By Application: Oncology, Metabolic Diseases, Developmental Biology, Immunology, Cardiovascular Diseases, Other Applications 4) By End-User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Other End Users Subsegments: 1) By Reagents: DNA Methylation Reagents, Histone Modification Reagents, RNA Modifications Reagents, Enzymes 2) By Enzymes: DNA Methyltransferases, Histone Acetyltransferases, Histone Deacetylases 3) By Instruments: Sequencers, PCR Machines, Microarray Platforms, Mass Spectrometers 4) By Kits: DNA Methylation Kits, Chromatin Immunoprecipitation (ChIP) Kits, RNA-Seq Kits, Bisulfite Conversion KitsWhat Is The Driver Of The Epigenetics Market?
An increasing focus on precision medicine is expected to propel the growth of the epigenetics market going forward. Precision medicine is a medical approach that considers an individual's genetic, environmental, and lifestyle information to customize treatment to their specific needs. Precision medicine in epigenetics uses individual epigenetic profiles and genetic data to create personalized healthcare strategies for more effective disease management and treatment of each patient. For instance, in March 2024, Novotech, an Australia-based biotechnology company, in 2023, 43% of the 217 FDA-approved oncology therapies were precision oncology treatments, with 78 incorporating DNA or NGS-detectable biomarkers. Therefore, an increasing focus on precision medicine is driving the growth of the epigenetics industry.Key Players In The Global Epigenetics Market
Major companies operating in the epigenetics market are Illumina Inc., Thermo Fisher Scientific, Merck Millipore, Active Motif, Abcam PLC, Qiagen NV, Diagenode SA, CellCentric Ltd., Chroma Medicine Inc., Constellation Pharmaceuticals Inc., Domainex Ltd., Eisai Co. Ltd., Epigen Biosciences Inc., EpigenDx Inc., Epigenomics AG, Epizyme Inc., Gilead Sciences Inc., GlaxoSmithKline plc, Janssen Pharmaceuticals Inc., MDxHealth SA, Novartis AG, OncoDNA SA, Oryzon Genomics S.A., Pfizer Inc., Syndax Pharmaceuticals Inc., Valirx plc
This chart is for illustrative purposes; the full report includes a detailed competitor analysis and comprehensive overview of the top 10 companies in the market.
This chart maps companies by product innovation and brand strength, with bubble size indicating relative revenue, helping identify market leaders, challengers, and niche players. This is an illustrative chart; the full report provides a complete and accurate competitive analysis.
Explore how leading companies compare across key metrics in our report Get Report
Global Epigenetics Market Trends and Insights
Major companies operating in the epigenetics market are increasing their focus on introducing artificial intelligence (AI)-driven analytics to gain a competitive edge in the market. AI-driven analytics is the process of using artificial intelligence (AI) technologies to automatically analyze and interpret large volumes of data. For instance, in July 2023, FOXO Technologies, a US-based company, launched Bioinformatics Services to revolutionize epigenetic data analysis. FOXO's Bioinformatics Services provide a versatile platform of advanced data solutions customized to address the specific requirements of clients engaged in academia, healthcare, and pharmaceutical research. Innovative bioinformatic tools Using an innovative suite of bioinformatic tools, FOXO aims to enable its clients to increase the speed and accuracy with which they process, analyze, and interpret data sets, accelerate discoveries, and advance their understanding of complex diseases.What Are Latest Mergers And Acquisitions In The Epigenetics Market?
In July 2023, New Day Diagnostics, a US-based provider of molecular and epigenetic diagnostic technologies, acquired substantially all of the assets of Epigenomics AG for an undisclosed amount. With this acquisition, New Day Diagnostics aims to strengthen its precision-epigenetic diagnostics portfolio, expand its cancer biomarker offerings, and enhance its technological capabilities in DNA methylation-based testing. Epigenomics AG is a Germany-based provider of DNA methylation-based in vitro diagnostic tests for cancer.
Regional Outlook
North America was the largest region in the epigenetics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the epigenetics market during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, SpainNeed data for a specific geography? Request Regional Data
What Defines the Epigenetics Market?
The epigenetics market includes revenues earned by entities methylation, acetylation, phosphorylation, ubiquitylation, and sumolyation. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This chart presents market attractiveness based on a quantitative evaluation of growth, competition, strategic alignment, and risk, offering a clear view of opportunity areas for decision-making. This chart is for illustrative purposes; the full report contains the complete analysis.
This chart highlights the Total Addressable Market (TAM) by estimating the maximum revenue opportunity using an assumption-driven approach, supporting strategic planning and opportunity sizing across markets. The chart is illustrative; the full report provides a more comprehensive analysis.
Access full TAM calculations and growth projections in our report Get Report
What Key Data and Analysis Are Included in the Epigenetics Market Report 2026?
The epigenetics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the epigenetics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Epigenetics Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $15.62 billion |
| Revenue Forecast In 2030 | $35.01 billion |
| Growth Rate | CAGR of 22.3% from 2026 to 2030 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2030 |
| Segments Covered | Product, Technology, Application, End-User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain. |
| Key Companies Profiled | Illumina Inc., Thermo Fisher Scientific, Merck Millipore, Active Motif, Abcam PLC, Qiagen NV, Diagenode SA, CellCentric Ltd., Chroma Medicine Inc., Constellation Pharmaceuticals Inc., Domainex Ltd., Eisai Co. Ltd., Epigen Biosciences Inc., EpigenDx Inc., Epigenomics AG, Epizyme Inc., Gilead Sciences Inc., GlaxoSmithKline plc, Janssen Pharmaceuticals Inc., MDxHealth SA, Novartis AG, OncoDNA SA, Oryzon Genomics S.A., Pfizer Inc., Syndax Pharmaceuticals Inc., Valirx plc |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |